2 Vaccine composition for preventing or treating infection of SARS-CoV-2

The present invention relates to a recombinant protein antigen for preventing or treating SARS-coronavirus-2 infection, including a receptor-binding domain (RBD) of an expanded spike protein of SARS-coronavirus-2, and a vaccine composition comprising the same. 본 발명은 확장된 사스-코로나바이러스-2의 스파이크 단백질 (spike...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KWON TEAWOO, LEE YOONJAE, SEO KI WEON, LEE SUJEEN, HONG SEUNG HYE, KIM EUN SOM
Format:	Patent
Sprache:	eng ; kor
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a recombinant protein antigen for preventing or treating SARS-coronavirus-2 infection, including a receptor-binding domain (RBD) of an expanded spike protein of SARS-coronavirus-2, and a vaccine composition comprising the same. 본 발명은 확장된 사스-코로나바이러스-2의 스파이크 단백질 (spike protein)의 리셉터 결합 도메인(RBD, receptor-binding domain)을 포함하는, 사스-코로나바이러스-2 감염증 예방 또는 치료용 재조합 단백질 항원 및 이를 포함하는 백신 조성물을 제공한다.